ClinConnect ClinConnect Logo
Search / Trial NCT02760576

18612 - Sun Protection Factor Assay

Launched by BAYER · May 2, 2016

Trial Information

Current as of June 24, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fitzpatrick Skin Type l, ll and/or lll for UVB testing; Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
  • Male and female.
  • Aged between 18-70 years old.
  • Good health as determined from the HRL SHF (Subject History Form).
  • Signed and dated Informed Consent Form.
  • Signed and dated HIPAA Form (Health Insurance Portability and Accountability Act).
  • An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose).
  • Exclusion Criteria:
  • Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
  • Pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
  • Pre-existing other medical conditions (e.g. adult asthma, diabetes).
  • Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
  • Treatment with antibiotics within two weeks prior to initiation of the test.
  • Chronic medication which could affect the results of the study.
  • Known pregnant or nursing women.

About Bayer

Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.

Locations

Union, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Bayer Study Director

Study Director

Bayer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials